Review of Existing Evidence on Single-Dose HPV Vaccination

Overview of evidence for decision making on single dose HPV schedules

Auteurs

Langues

Année de publication

2022

Type

Catégories

Maladies

Organisations

HPV-INTRO-SINGLE

Cette ressource est incluse dans le tableau suivant:

Titre	Auteur	Année	Type	Langue
Changes in HPV Vaccination Coverage, Implementation, and Sustainability Following the Switch to a Single-Dose Schedule: A Mixed-Methods Analysis	International Vaccine Access Center (IVAC)	2026	Report	Anglais
Considerations for Human Papillomavirus (HPV) Vaccine Product Choice: Second Edition	World Health Organization (WHO)	2024	Guidance	Anglais
HPV VACCINE SCHEDULE OPTIMIZATION Key considerations for decision-making, planning, and implementation	PATH, JSI, UNICEF, Gavi, the Vaccine Alliance, Clinton Health Access Initiative (CHAI), Jhpiego, International Vaccine Access Center (IVAC), Centers for Disease Control and Prevention (CDC), John Hopkins Bloomberg School of Public Health	2023	Guidance	Anglais, Français, Portuguais, Russe, Espagnol
Review of Existing Evidence on Single-Dose HPV Vaccination	Single dose consortium	2022	Presentation	Anglais, Français
The Operational Impact of Switching from a Two-Dose to a One-Dose HPV Vaccination Schedule: Lessons Learned from Burkina Faso, Ethiopia, and Solomon Islands	PATH	2025	Report	Anglais

Ajouté par: Paul Bloem

Ajouté le: 2023-03-10 08:45:02

Consultations: 2311

Présentation